HARMONY BIOSCIENCES ANNOUNCES DATE OF SECOND QUARTER 2022 FINANCIAL RESULTS

PLYMOUTH MEETING, Pa., July 19, 2022 /PRNewswire/ — Harmony Biosciences Holdings, Inc. (“Harmony” or the “Company”) (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases, today announced that…

About the Author

has written 41562 stories on this site.

Copyright © 2010 Business and Corporate News.